Representation of Variantyx during its $41.5 million funding round

14 February, 2022

Advs. Kobi Ben Chitrit, David Roness, Eyal Safrai and interns Aliza Haber Feld and Yaara Sari represented Technology-Driven Precision Medicine Company Variantyx in a series C-2 funding round, led by New Era Capital Partners.

This will be used to fuel company growth and launch newly developed solutions across all markets, with a focus on precision oncology.

Read full article >>

Want to know more?
Contact us

Shiri Menache

Head of Marketing and Business Development

Matan Bar-Nir

Press Officer, OH! PR